Josef highlights the stark contrast between short-term and long-term side effects of drugs, emphasizing that while initial trials may identify immediate risks, ongoing marketing efforts often downplay or ignore potential long-term issues. He points out the lack of incentive for pharmaceutical companies to disclose risks once a drug is on the market, leading to a proliferation of positive narratives that overshadow safety concerns.
